533212 — GKB Ophthalmics Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹291.85m
- IN₹445.65m
- IN₹1.09bn
- 29
- 67
- 15
- 26
Annual cashflow statement for GKB Ophthalmics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.28 | 19.5 | 1.39 | -27.8 | -67.3 |
| Depreciation | |||||
| Non-Cash Items | 21.8 | 8.49 | 10.6 | 10 | 62.7 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -80.5 | -3.96 | -68 | 30.9 | -60.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -36.6 | 50.7 | -27.7 | 42.2 | -34.3 |
| Capital Expenditures | -63.3 | -47.6 | -16.6 | -20.8 | -21.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.722 | 12.3 | 30.9 | 3.64 | 47 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -62.6 | -35.2 | 14.3 | -17.1 | 25.5 |
| Financing Cash Flow Items | -20 | -14.5 | -16.5 | -19.1 | -23.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 27.7 | -16.6 | -21.9 | -16.4 | 6.69 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -71.5 | -1.21 | -35.3 | 8.68 | -2.11 |